Sign in
4

Changes in Ownership

Aprea Therapeutics, Inc. Filed Acc 0001140361-21-006738

SVP, Chief Medical Officer acquired 108,000 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Table I: Non-derivative

Insider Date Transaction Shares Price Value Owned after D/I
Attar Eyal C. SVP, Chief Medical Officer 2021-02-25 Grant or award +33,000 33,000 D: show line 1 in the form
Attar Eyal C. SVP, Chief Medical Officer 2021-02-25 Grant or award +75,000 108,000 D: show line 2 in the form

Table II: Derivative

Insider Date Transaction Shares Price Value Owned after D/I
Attar Eyal C. SVP, Chief Medical Officer 2021-02-25 Grant or award · Stock Option (right to Buy) +143,000 143,000 D: show line 3 in the form
Loading xslF345X03/form4.xml…